Dr. Carpenter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-228-1000- Is this information wrong?
Education & Training
- University of Sydney Faculty of MedicineClass of 1988
Certifications & Licensure
- WA State Medical License 2001 - 2025
- AK State Medical License 2022 - 2024
Publications & Presentations
PubMed
- Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplan...Anna Sureda, Paul A Carpenter, Andrea Bacigalupo, Vijaya Raj Bhatt, Josu de la Fuente, Aloysius Ho, Leslie Kean, Jong Wook Lee, Isabel Sánchez-Ortega, Bipin N Savani, ...> ;Bone Marrow Transplantation. 2024 Mar 5
- Facilitators and Barriers to Successful Revaccination after Hematopoietic Stem Cell Transplantation among Adult Survivors: A Scoping Review.Mihkai Wickline, Gemma McErlean, Sarah Iribarren, Kerryn Reding, Donna L Berry, Paul A Carpenter> ;Transplantation and Cellular Therapy. 2024 Mar 1
- International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update.Seth J Rotz, Neel S Bhatt, Betty K Hamilton, Christine Duncan, Mahmoud Aljurf, Yoshiko Atsuta, Kristen Beebe, David Buchbinder, Peggy Burkhard, Paul A Carpenter, Naeem...> ;Bone Marrow Transplantation. 2024 Feb 27
- Join now to see all
Press Mentions
- FDA Approves Ibrutinib (Imbruvica) for Graft-Versus-Host Disease in Children, Young AdultsAugust 25th, 2022
- The U.S. Food and Drug Administration Approved the Use of IMBRUVICA for the Treatment of Pediatric Patients One Year and Older with cGVHD After Failure of One or More Lines of Systemic TherapyAugust 24th, 2022
- (Ibrutinib) as First and Only BTKi Treatment for Pediatric Patients with Chronic Graft-Versus-Host DiseaseAugust 24th, 2022
- Join now to see all
Hospital Affiliations
- Seattle Children's HospitalSeattle, Washington
- Fred Hutchinson Cancer CenterSeattle, Washington
- UW Medicine/University of Washington Medical CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: